Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cerebello-motor Neuromodulation After Stroke. CERSTIM.

NCT: NCT06599931 · RECRUITING

NCT IDNCT06599931
StatusRECRUITING
Start Date2024-12-13
Completion2027-12-30

Brief Summary

The CERSTIM study is a physiopatholgical study investigating transcranial alternating current stimulation in stroke patients in the cerebello-motor loop. The design is a cross over design testing two frequencies in the gamma band and one placebo. We will use behavioural data, functional MRI, and Electroencephalography to disentangle the effect of tACS and its frequency. Healthy participants will be also recruited.

Frequently Asked Questions

What is Cerebello-motor Neuromodulation After Stroke. CERSTIM.?

Cerebello-motor Neuromodulation After Stroke. CERSTIM. is a clinical trial registered under NCT06599931. Current status: RECRUITING.

What is the status of NCT06599931?

The current status of NCT06599931 (Cerebello-motor Neuromodulation After Stroke. CERSTIM.) is: RECRUITING.

When did Cerebello-motor Neuromodulation After Stroke. CERSTIM. start?

Cerebello-motor Neuromodulation After Stroke. CERSTIM. started on 2024-12-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.